Gapping down
In reaction to disappointing earnings/guidance: TPX -22%, SYMX -8.4%, FGP -7.3%, SONC -5.2%, NKE -2.6%
M&A news:
- RAD -2.1% (NY Post reports tepid PE interest in some 650 stores Walgreens is lokoing to divest to get a deal done)
- GLBL -1.2% (reaches agreement with subsidiaries of SunEdison to buy certain assets from a third party buyer)
Other news:
- GALT -47.8% (announces top-line data from exploratory Phase 2a pilot trial; trial also did not meet primary or secondary endpoints; entered into a Securities Purchase Agreement)
- SCSS -7.7% (TPX sympathy)
- VSAR -6.3% (commences common stock offering for undisclosed amount)
- FOMX -4% (commences public offering of its ordinary shares w/ a portion of the shares being sold by certain selling shareholders )
- RGSE -3% (after surging 150% higher)
- GSBD -1.8% (light volume-plans to conduct an offering of up to $100 million aggregate principal amount of convertible notes due 2022 )
- GXP -1.5% (prices offerings of common stock and depositary shares; prices 52.6 mln shares at $26.45)
- FL -1.1% (following Nike earnings)
Analyst comments:
- SEM -2.8% (downgraded to Mkt Underperform from Mkt Perform at JMP Securities)
- BIDU -2.3% (downgraded to Hold from Buy at Deutsche Bank)
- T -1% (downgraded to Neutral from Buy at UBS)
- TWTR -0.9% (downgraded to Underperform from Neutral at Mizuho)
- M -0.8% (downgraded to Neutral from Outperform at Credit Suisse)
- GOOGL -0.6% (downgraded to Underperform from Neutral at Wedbush)